The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmiths Group Regulatory News (SMIN)

Share Price Information for Smiths Group (SMIN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,739.00
Bid: 1,739.00
Ask: 1,740.00
Change: -1.00 (-0.06%)
Spread: 1.00 (0.058%)
Open: 1,736.00
High: 1,740.00
Low: 1,730.00
Prev. Close: 1,740.00
SMIN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disposal

1 Jun 2017 14:00

RNS Number : 8693G
Smiths Group PLC
01 June 2017
 

 

News Release

London, 1 June 2017

For immediate release

 

 

Smiths Group agrees to sell Morpho Detection's former trace business

Smiths Group plc ("Smiths Group") today announces that it has entered into a binding agreement with OSI Systems, Inc to sell the explosive trace detection business formerly owned by Morpho Detection (the "Trace Business") for an enterprise value of $75.5 million.

In connection with its acquisition of Morpho Detection from Safran, Smiths Group had made commitments to the European Commission ("EC") and the Department of Justice ("DOJ") to sell the Trace Business. The sale is conditional upon regulatory approval in Portugal and the approval by the EC and DOJ of OSI Systems, Inc as a suitable purchaser. Completion is expected in mid-2017.

 

ENDS

 

Contact details

Marion Le Bot, Smiths Group

+44 (0)20 7004 1672

+44 (0)75 8315 4386

marion.lebot@smiths.com 

 

Media enquiries

Andrew Lorenz, FTI Consulting

+44 (0)203 727 1323

+44 (0)777 564 1807

smiths@fticonsulting.com

 

Deborah Scott, FTI Consulting

+44 (0)203 727 1459

+44 (0)797 953 7449

smiths@fticonsulting.com

 

 

Smiths Group is a global technology company listed on the London Stock Exchange (SMIN) and operates a sponsored level one ADR programme (SMGZY). A world leader in the practical application of advanced technologies, Smiths Group delivers products and services for the threat & contraband detection, medical devices, energy and communications markets worldwide. Smiths Group employs more than 22,000 people in over 50 countries. For more information visit www.smiths.com.

 

 

Disclaimer

This announcement contains certain statements that are forward-looking statements. They appear in a number of places throughout this announcement and include statements regarding our intentions, beliefs or current expectations and those of our officers, directors and employees concerning, amongst other things, our results of operations, financial condition, liquidity, prospects, growth, strategies and the business we operate. By their nature, these statements involve uncertainty since future events and circumstances can cause results and developments to differ materially from those anticipated. The forward-looking statements reflect knowledge and information available at the date of preparation of this announcement and, unless otherwise required by applicable law, Smiths undertakes no obligation to update or revise these forward-looking statements. Nothing in this document should be construed as a profit forecast.

 

No statement in this announcement is intended to be a profit forecast and no statement in this announcement should be interpreted to mean that earnings per Smiths ordinary share for the current or future financial years would necessarily match or exceed the historical published earnings per Smiths ordinary share. Prices and values of, and income from, shares may go down as well as up and an investor may not get back the amount invested. It should be noted that past performance is no guide to future performance. Persons needing advice should consult an independent financial adviser.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISLLFSIRIILIID
Date   Source Headline
1st Sep 202011:00 amRNSTotal Voting Rights
6th Aug 20202:06 pmRNSDirector/PDMR Shareholding
3rd Aug 20201:06 pmRNSDirector/PDMR Shareholding
31st Jul 20205:00 pmRNSTotal Voting Rights
30th Jun 20205:00 pmRNSTotal Voting Rights
30th Jun 20207:00 amRNSTrading update & strategic restructuring
22nd Jun 20209:33 amRNSAdditional Listing
20th May 20209:30 amRNSDirector/PDMR Shareholding
1st May 202011:00 amRNSBlock listing Interim Review
1st May 202010:45 amRNSDirector/PDMR Shareholding
30th Apr 20205:15 pmRNSTotal Voting Rights
30th Apr 20202:30 pmRNSDirector/PDMR Shareholding
27th Apr 20202:56 pmRNSDoc re. Listing Rule 9.2.6E
16th Apr 20204:15 pmRNSHolding(s) in Company
6th Apr 20207:00 amRNSInterim Results
31st Mar 20207:00 amRNSTrading Update
27th Mar 20203:47 pmRNSFCA moratorium on publication of results
3rd Feb 20203:57 pmRNSDirector/PDMR Shareholding
31st Jan 20205:00 pmRNSTotal Voting Rights
8th Jan 20204:38 pmRNSDirectorate Change
2nd Jan 20202:30 pmRNSTotal Voting Rights
2nd Dec 20199:00 amRNSTotal Voting Rights
13th Nov 201912:57 pmRNSResult of AGM
13th Nov 20197:00 amRNSSmiths Group FY2020 Q1 Trading Statement
11th Nov 201910:57 amRNSDirector/PDMR Shareholding
4th Nov 20194:45 pmRNSBlock listing Interim Review
1st Nov 201910:30 amRNSDirector/PDMR Shareholding
1st Nov 201910:30 amRNSTotal Voting Rights
11th Oct 20198:00 amRNSAnnual Financial Report
9th Oct 20192:52 pmRNSDirector/PDMR Shareholding
7th Oct 20194:08 pmRNSDirector/PDMR Shareholding
30th Sep 20195:56 pmRNSTotal Voting Rights
20th Sep 20197:00 amRNSSmiths Group plc Annual Results FY2019
2nd Sep 20199:30 amRNSTotal Voting Rights
5th Aug 20193:27 pmRNSDirector/PDMR Shareholding
1st Aug 201910:30 amRNSDirector/PDMR Shareholding
31st Jul 20195:15 pmRNSTotal Voting Rights
30th Jul 20199:01 amRNSAdditional Listing
26th Jul 20192:00 pmRNSHolding(s) in Company
25th Jul 20191:00 pmRNSDirectorate Change
3rd Jul 20197:00 amRNSSmiths Group extends pension de-risking
1st Jul 201910:47 amRNSTotal Voting Rights
7th Jun 20197:00 amRNSAppointment of Smiths Medical CEO
3rd Jun 20199:00 amRNSTotal Voting Rights
10th May 20191:30 pmRNSDirector/PDMR Shareholding
2nd May 20194:20 pmRNSDirector Declaration
1st May 20199:49 amRNSDirector/PDMR Shareholding
1st May 20199:30 amRNSBlock listing Interim Review
1st Apr 20199:00 amRNSTotal Voting Rights
22nd Mar 20197:01 amRNSSmiths plans for separation of Smiths Medical

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.